OXYSOME™ is a high-purity stem cell support product created by suspending 5 billion exosomes, obtained from the patient's bone marrow-derived CD34+ Hematopoietic Stem Cells or HUVEC (Human Vascular Endothelial Cell) culture, in 2-5 ml of physiological saline.

​

Mechanism of Action

OXYSOME™ works by carrying molecular messages from stem cells that are responsible for the formation of blood vessels and blood cells in the body:

​

Neovascularization (New Blood Vessel Formation): Thanks to its rich content of VEGF (Vascular Endothelial Growth Factor), signaling molecules, and microRNAs, it triggers new blood vessel formation at the molecular level in the area where it is applied.

​

Improving Microcirculation: By strengthening the vascular structure, it increases tissue perfusion (blood flow) and allows for the re-nourishment of ischemic (deficient blood supply) tissues.

​

Cellular Signaling: It delivers the healing power of stem cells to the damaged vascular endothelium via vesicles without the need for cell transplantation.

​

Application Method

OXYSOME™ is recommended as a supportive treatment for nutritional deficiencies occurring in end-organs such as the heart, brain, eyes, and feet (diabetic foot, etc.) due to ischemic conditions, post-traumatic injuries, or systemic diseases. It can be administered via different methods such as IV (intravenous), intradermal, intra-articular, or intralesional under the supervision of a specialist physician.